Report cover image

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Mar 29, 2024
Length 105 Pages
SKU # GBDT18743635

Description

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Hyaluronic Acid Fillers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of total HA is found in the skin, and it is produced by dermal fibroblasts, endothelial cells, synovial cells, adventitial cells, smooth muscle cells, and oocytes. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hyaluronic Acid Fillers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hyaluronic Acid Fillers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hyaluronic Acid Fillers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

105 Pages
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Hyaluronic Acid Fillers Overview
4 Products under Development
4.1 Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
4.2 Hyaluronic Acid Fillers - Pipeline Products by Segment
4.3 Hyaluronic Acid Fillers - Pipeline Products by Territory
4.4 Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
4.5 Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
4.6 Hyaluronic Acid Fillers - Ongoing Clinical Trials
5 Hyaluronic Acid Fillers - Pipeline Products under Development by Companies
5.1 Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
5.2 Hyaluronic Acid Fillers – Companies Pipeline Products by Stage of Development
6 Hyaluronic Acid Fillers Companies and Product Overview
6.1 Allergan Aesthetics Company Overview
6.1.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
6.2 Almirall Ltd Company Overview
6.2.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.3 Aquavit Pharmaceuticals Inc Company Overview
6.3.1 Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 BioPlus Co Ltd Company Overview
6.4.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 BioSmart Nanotechnology Ltda Company Overview
6.5.1 BioSmart Nanotechnology Ltda Pipeline Products & Ongoing Clinical Trials Overview
6.6 BMG Pharma SpA Company Overview
6.6.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview
6.7 Bmi Korea Co Ltd Company Overview
6.7.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.8 CellPraxis Company Overview
6.8.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview
6.9 Collplant Biotechnologies Ltd Company Overview
6.9.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.1 Croma-Pharma GmbH Company Overview
6.10.1 Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.11 Evolus Inc Company Overview
6.11.1 Evolus Inc Pipeline Products & Ongoing Clinical Trials Overview
6.12 Fillmed Laboratoires Company Overview
6.12.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview
6.13 Hallura Ltd Company Overview
6.13.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.14 Hugel Inc Company Overview
6.14.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Jinwoo Bio Co Ltd Company Overview
6.15.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.16 Laboratoires Vivacy Company Overview
6.16.1 Laboratoires Vivacy Pipeline Products & Ongoing Clinical Trials Overview
6.17 LG Chem Ltd Company Overview
6.17.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.18 LifeSprout Inc Company Overview
6.18.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 Medytox Inc Company Overview
6.19.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Merz Aesthetics Company Overview
6.20.1 Merz Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
6.21 Mesoestetic Pharma Group SL Company Overview
6.21.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
6.22 Oligo Medic Inc Company Overview
6.22.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
6.23 Q-Med AB Company Overview
6.23.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview
6.24 Shanghai Haohai Biological Technology Co Ltd Company Overview
6.24.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.25 Shin Poong Pharm Co Ltd Company Overview
6.25.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.26 Silk Medical Aesthetics Inc Company Overview
6.26.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.27 Sinclair Pharma Ltd Company Overview
6.27.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.28 SwiftPharma BV Company Overview
6.28.1 SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview
6.29 Teoxane SA Company Overview
6.29.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview
6.3 Tissueform Inc Company Overview
6.30.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview
6.31 TruElastin Laboratories Inc Company Overview
6.31.1 TruElastin Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
7 Hyaluronic Acid Fillers- Recent Developments
7.1 Mar 05, 2024: JUVEDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval
7.2 Mar 05, 2024: JUVÉDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval
7.3 Mar 04, 2024: Revance Therapeutics Announces Proposed $100M Share Offering
7.4 Mar 01, 2024: Evolus Announces Results from European Head-to-Head Filler Trial
7.5 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
7.6 Feb 27, 2024: LG Chem to Raise 1 tln Won in Bond Sale
7.7 Feb 22, 2024: AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel
7.8 Feb 07, 2024: Galderma Launches ‘Next’, a Ground-Breaking Trend Report That Unveils the Future of Aesthetics
7.9 Feb 05, 2024: AbbVie's Full Year 2023 Sees 6.4% Net Revenue Drop
7.1 Jan 22, 2024: Galderma Announces Regulatory Approval for Restylane SHAYPE, a new Hyaluronic Acid Injectable Designed for Augmenting the Chin Region
7.11 Jan 04, 2024: AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call
7.12 Jan 03, 2024: Medytox Announces Executive Appointments in Luvantas, Inc
7.13 Nov 01, 2023: CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
7.14 Oct 31, 2023: SKINVIVE by JUVEDERM Now Available from Dermatologist Dr. Ellen Turner
7.15 Oct 31, 2023: LG Chem Announces 3Q Management Performance
7.16 Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
7.17 Oct 04, 2023: AbbVie to Host Third-Quarter 2023 Earnings Conference Call
7.18 Sep 28, 2023: Merz Aesthetics Continues to Fuel Confidence by Expanding Belotero Balance (+) Filler Treatment Areas
7.19 Sep 19, 2023: Revance Provides Corporate Update at Investor Day
7.2 Sep 01, 2023: Shanghai Haohai Biological Technology Co. Announces Interim Report 2023
7.21 Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
7.22 Aug 01, 2023: Allergan Aesthetics Announces First Ever JUVEDERM Day
7.23 Jun 26, 2023: Collplant Achieves Milestone and to Receive $10 Million From Abbvie in Accordance With Its Regenerative Dermal Filler Product Collaboration Agreement
7.24 Jun 12, 2023: Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
7.25 May 15, 2023: SKINVIVE by JUVÉDERM receives U.S. FDA approval
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
Table 2: Hyaluronic Acid Fillers - Pipeline Products by Segment
Table 3: Hyaluronic Acid Fillers - Pipeline Products by Territory
Table 4: Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
Table 5: Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
Table 6: Hyaluronic Acid Fillers - Ongoing Clinical Trials
Table 7: Hyaluronic Acid Fillers Companies - Pipeline Products by Stage of Development
Table 8: Hyaluronic Acid Fillers – Companies Pipeline Products by Stage of Development
Table 9: Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview
Table 10: HA Threads - Product Status
Table 11: HA Threads - Product Description
Table 12: Juvederm - Decolletage - Product Status
Table 13: Juvederm - Decolletage - Product Description
Table 14: Juvederm - Hands - Product Status
Table 15: Juvederm - Hands - Product Description
Table 16: Juvederm Voluma - Nose - Product Status
Table 17: Juvederm Voluma - Nose - Product Description
Table 18: Juvederm Voluma Global - Malar Augmentation - Product Status
Table 19: Juvederm Voluma Global - Malar Augmentation - Product Description
Table 20: JUVEDERM VOLUMA XC - Temple Augmentation - Product Status
Table 21: JUVEDERM VOLUMA XC - Temple Augmentation - Product Description
Table 22: Allergan Aesthetics - Ongoing Clinical Trials Overview
Table 23: Juvederm Voluma Global - Malar Augmentation - Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis
Table 24: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Hyaluronic Acid Facial Filler - Product Status
Table 26: Hyaluronic Acid Facial Filler - Product Description
Table 27: Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Aquabelo - Product Status
Table 29: Aquabelo - Product Description
Table 30: BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 31: HyalDew All - Product Status
Table 32: HyalDew All - Product Description
Table 33: HyalDew Fine - Product Status
Table 34: HyalDew Fine - Product Description
Table 35: HyalDew Shine - Product Status
Table 36: HyalDew Shine - Product Description
Table 37: HyalDew-Mid - Product Status
Table 38: HyalDew-Mid - Product Description
Table 39: BioSmart Nanotechnology Ltda Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Hyaluronic Acid Dermal Filler - Product Status(BioSmart Nanotechnology Ltda)
Table 41: Hyaluronic Acid Dermal Filler - Product Description(BioSmart Nanotechnology Ltda)
Table 42: BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 43: SGA300 - Product Status
Table 44: SGA300 - Product Description
Table 45: SGA302 - Product Status
Table 46: SGA302 - Product Description
Table 47: Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 48: BMI4002 - Product Status
Table 49: BMI4002 - Product Description
Table 50: CellPraxis Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Lipage - Product Status
Table 52: Lipage - Product Description
Table 53: Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 54: rhCollagen Based Photocurable Regenerative Dermal Filler - Product Status
Table 55: rhCollagen Based Photocurable Regenerative Dermal Filler - Product Description
Table 56: Croma-Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Saypha Volume Plus Lidocaine - Product Status
Table 58: Saypha Volume Plus Lidocaine - Product Description
Table 59: Croma-Pharma GmbH - Ongoing Clinical Trials Overview
Table 60: Saypha Volume Plus Lidocaine - A Randomized, Multi-center, Evaluator-blinded, Parallel Assignment, Active Controlled Study to Evaluate the Efficacy and Safety of Princess Voluma plus and Restylane Perlane Lidocaine for Correction of Midface Volume Deficit And/Or Midface Contour Deficiency
Table 61: Evolus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Evolysse Eye Infraorbital Hollows Filler - Product Status
Table 63: Evolysse Eye Infraorbital Hollows Filler - Product Description
Table 64: Evolysse Lift Nasolabial Folds Filler - Product Status
Table 65: Evolysse Lift Nasolabial Folds Filler - Product Description
Table 66: Evolysse Lips Volumizing And Countering Filler - Product Status
Table 67: Evolysse Lips Volumizing And Countering Filler - Product Description
Table 68: Evolysse Sculpt Mid Face Volume Filler - Product Status
Table 69: Evolysse Sculpt Mid Face Volume Filler - Product Description
Table 70: Evolysse Smooth Nasolabial Folds Filler - Product Status
Table 71: Evolysse Smooth Nasolabial Folds Filler - Product Description
Table 72: Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview
Table 73: NCTF 135 - Product Status
Table 74: NCTF 135 - Product Description
Table 75: NCTF 135 HA - Product Status
Table 76: NCTF 135 HA - Product Description
Table 77: Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 78: BiOLinkMatrix Gel - Product Status
Table 79: BiOLinkMatrix Gel - Product Description
Table 80: Hyaluronic Acid Dermal Filler - Product Status(Hallura Ltd)
Table 81: Hyaluronic Acid Dermal Filler - Product Description(Hallura Ltd)
Table 82: Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: The Chaeum Pure No.1 - Product Status
Table 84: The Chaeum Pure No.1 - Product Description
Table 85: The Chaeum Pure No.2 - Product Status
Table 86: The Chaeum Pure No.2 - Product Description
Table 87: The Chaeum Pure No.3 - Product Status
Table 88: The Chaeum Pure No.3 - Product Description
Table 89: The Chaeum Pure No.4 - Product Status
Table 90: The Chaeum Pure No.4 - Product Description
Table 91: The Chaeum Style - Product Status
Table 92: The Chaeum Style - Product Description
Table 93: Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 94: HA Filler - Product Status
Table 95: HA Filler - Product Description
Table 96: HA Thread Filler - Product Status
Table 97: HA Thread Filler - Product Description
Table 98: Wool Filler - Product Status
Table 99: Wool Filler - Product Description
Table 100: Laboratoires Vivacy Pipeline Products & Ongoing Clinical Trials Overview
Table 101: IPN-21-SENSE Dermal Filler - Product Status
Table 102: IPN-21-SENSE Dermal Filler - Product Description
Table 103: Laboratoires Vivacy - Ongoing Clinical Trials Overview
Table 104: IPN-21-SENSE Dermal Filler - A Multicenter, Prospective, Randomized Controlled Clinical Study of IPN-21-SENSE, a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face
Table 105: LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Dermal Filler (LR19093) - Product Status
Table 107: Dermal Filler (LR19093) - Product Description
Table 108: Hyaluronic Acid Filler (LR19094) - Product Status
Table 109: Hyaluronic Acid Filler (LR19094) - Product Description
Table 110: Hyaluronic Acid Filler (LR20023) - Product Status
Table 111: Hyaluronic Acid Filler (LR20023) - Product Description
Table 112: Hyaluronic Acid Filler (LR20024) - Product Status
Table 113: Hyaluronic Acid Filler (LR20024) - Product Description
Table 114: Next Generation Hyaluronic Acid Filler (LR20008) - Product Status
Table 115: Next Generation Hyaluronic Acid Filler (LR20008) - Product Description
Table 116: YVOIRE Y-Solution 360 - Product Status
Table 117: YVOIRE Y-Solution 360 - Product Description
Table 118: YVOIRE Y-Solution 540 - Product Status
Table 119: YVOIRE Y-Solution 540 - Product Description
Table 120: YVOIRE Y-Solution 720 - Product Status
Table 121: YVOIRE Y-Solution 720 - Product Description
Table 122: LG Chem Ltd - Ongoing Clinical Trials Overview
Table 123: YVOIRE Y-Solution 360 - A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation
Table 124: YVOIRE Y-Solution 540 - A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection
Table 125: LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 126: Lumina - Product Status
Table 127: Lumina - Product Description
Table 128: LifeSprout Inc - Ongoing Clinical Trials Overview
Table 129: Lumina - A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds
Table 130: Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Neuramis Deep Lidocaine - Product Status
Table 132: Neuramis Deep Lidocaine - Product Description
Table 133: Neuramis Volume Lidocaine - Product Status
Table 134: Neuramis Volume Lidocaine - Product Description
Table 135: Merz Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 6
Table 136: VP1 Lido US - Product Status 6
Table 137: VP1 Lido US - Product Description 6
Table 138: Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
Table 139: LIFT001 - Product Status
Table 140: LIFT001 - Product Description
Table 141: mRDX-02-17 - Product Status
Table 142: mRDX-02-17 - Product Description
Table 143: Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 144: AntaRep - Product Status
Table 145: AntaRep - Product Description
Table 146: Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview
Table 147: GAL1906 - Product Status
Table 148: GAL1906 - Product Description
]Table 149: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 150: Organic Cross-Linked HA Dermal Filler - Product Status
Table 151: Organic Cross-Linked HA Dermal Filler - Product Description
Table 152: Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 153: FreeWink - Product Status
Table 154: FreeWink - Product Description
Table 155: Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 156: Dermal Filler - Product Status
Table 157: Dermal Filler - Product Description
Table 158: SMA-001 - Product Status
Table 159: SMA-001 - Product Description
Table 160: Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 161: Atlean - Product Status
Table 162: Atlean - Product Description
Table 163: MaiLi - Product Status 6
Table 164: MaiLi - Product Description 6
Table 165: MaiLi Extreme - Product Status 6
Table 166: MaiLi Extreme - Product Description 7
Table 167: Perfectha G - Product Status 7
Table 168: Perfectha G - Product Description 7
Table 169: Sinclair Pharma Ltd - Ongoing Clinical Trials Overview
Table 170: MaiLi Extreme - A Post Market Clinical Follow Up (PMCF) Study to Assess the Safety and Efficacy of MaiLi Volume and MaiLi Extreme in the Treatment of Temporal Hollowing, Mid-Face Volume Deficit, Jawline Ptosis, and Chin Retrusion
Table 171: SwiftPharma BV Pipeline Products & Ongoing Clinical Trials Overview
Table 172: Injectable Dermal Filler - Product Status
Table 173: Injectable Dermal Filler - Product Description
Table 174: Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview
Table 175: Teosyal RHA 1 - Product Status
Table 176: Teosyal RHA 1 - Product Description
Table 177: Teoxane SA - Ongoing Clinical Trials Overview
Table 178: Teosyal RHA 1 - A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers
Table 179: Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 180: PureVoluma - Product Status
Table 181: PureVoluma - Product Description
Table 182: TruElastin Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 183: TEL219 - Product Status
Table 184: TEL219 - Product Description
Table 185: Glossary
2.2 List of Figures
Figure 1: Hyaluronic Acid Fillers - Pipeline Products by Stage of Development
Figure 2: Hyaluronic Acid Fillers - Pipeline Products by Segment
Figure 3: Hyaluronic Acid Fillers - Pipeline Products by Territory
Figure 4: Hyaluronic Acid Fillers - Pipeline Products by Regulatory Path
Figure 5: Hyaluronic Acid Fillers - Pipeline Products by Estimated Approval Date
Figure 6: Hyaluronic Acid Fillers - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us